Is Regeneron Pharmaceuticals, Inc. an American company?
Yes — Regeneron Pharmaceuticals, Inc. is an American company.
Regeneron Pharmaceuticals, Inc. is incorporated in New York, United States and headquartered in Tarrytown, New York. Its legal-entity record reports no foreign parent — the company is independently American-owned.
The evidence
- Legal name
- REGENERON PHARMACEUTICALS, INC.
- Incorporated in
- New York, United States
- Registered office
- NEW YORK, the United States
- Headquarters
- Tarrytown, New York, United States
- Ultimate owner
- None reported (independent)
- Stock listing
- NASDAQ: REGN on NASDAQ
- LEI
- 549300RCBFWIRX3HYQ56
Source: GLEIF, the global Legal Entity Identifier registry · checked Jul 26, 2026. A US headquarters or stock listing does not always mean US incorporation — this page reports what the legal-entity registry actually records.
Regeneron Pharmaceuticals, Inc.: origin questions
Is Regeneron Pharmaceuticals, Inc. an American company?
Yes — Regeneron Pharmaceuticals, Inc. is an American company. Regeneron Pharmaceuticals, Inc. is incorporated in New York, United States and headquartered in Tarrytown, New York. Its legal-entity record reports no foreign parent — the company is independently American-owned.
Where is Regeneron Pharmaceuticals, Inc. incorporated?
Regeneron Pharmaceuticals, Inc. is legally incorporated in New York, United States, according to its GLEIF legal-entity record.
Who owns Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. reports no parent company in its legal-entity record — it is independently owned rather than a subsidiary.
Is Regeneron Pharmaceuticals, Inc. traded on a US stock exchange?
Yes — Regeneron Pharmaceuticals, Inc. trades under the ticker REGN on the NASDAQ.
See the full Regeneron Pharmaceuticals, Inc. company profile — financials, stock data and trust credentials — or browse the directory of American companies.